The pain device, marketed for a wide range of conditions including arthritis, carpal tunnel syndrome and tendinitis, delivers an electromagnetic field deep into tissues to generate therapeutic heating up to 4 centimeters below the skin’s surface. Equity for the company’s four-pound ReBound device has increased from $500,000 to $850,000 since July.
ReBound, which the company says decreases pain while increasing mobility, comes with several different “therapy garments” that contain heating coils and fit over various body parts.
Related Articles on Pain Management:
West Virginia Gov. Signs Bill to Curb “Doctor Shopping”
Opioids Increasingly Prescribed for Chronic Abdominal Pain, Study Says
Soldiers Need Greater Emphasis on Pain Management Treatment, Physician Says
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
